Pharsight

Vanos patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7794738 BAUSCH Compositions and methods for enhancing corticosteroid delivery
Sep, 2022

(1 year, 6 months ago)

US7220424 BAUSCH Compositions and methods for enhancing corticosteroid delivery
Jan, 2023

(1 year, 2 months ago)

US8232264 BAUSCH Compositions and methods for enhancing corticosteroid delivery
Mar, 2023

(1 year, 21 days ago)

Vanos is owned by Bausch.

Vanos contains Fluocinonide.

Vanos has a total of 3 drug patents out of which 3 drug patents have expired.

Expired drug patents of Vanos are:

  • US7794738
  • US7220424
  • US8232264

Vanos was authorised for market use on 11 February, 2005.

Vanos is available in cream;topical dosage forms.

Vanos can be used as relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 years of age or older.

The generics of Vanos are possible to be released after 09 March, 2023.

Drugs and Companies using FLUOCINONIDE ingredient

Market Authorisation Date: 11 February, 2005

Treatment: Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 years of age or older

Dosage: CREAM;TOPICAL

How can I launch a generic of VANOS before it's drug patent expiration?
More Information on Dosage

VANOS family patents

Family Patents